<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Brain-derived neurotrophic factor (BDNF) has been shown to have therapeutic effects on <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>However, the delivery approach limits its application </plain></SENT>
<SENT sid="2" pm="."><plain>Laminin is a rich extra cellular matrix in the central <z:mp ids='MP_0008912'>nervous</z:mp> system, and is highly expressed in the ischemic region after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>We reported here by fusing with laminin-binding domain (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBD</z:e>) to BDNF to construct laminin-binding BDNF (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBD</z:e>-BDNF) </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBD</z:e>-BDNF could target accumulated laminin in the ischemic region and exert targeting therapy of injured neurons after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>We examined the laminin-binding ability and neurotrophic bioactivity of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBD</z:e>-BDNF in vitro, and assessed its targeting therapy using a rat permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) model in vivo </plain></SENT>
<SENT sid="6" pm="."><plain>It was found that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBD</z:e>-BDNF could specifically bind to laminin and maintain BDNF activity both in vitro and in vivo </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBD</z:e>-BDNF treatment attenuated neural-degeneration after MCAO, and also resulted in a reduction of <z:mpath ids='MPATH_124'>infarct</z:mpath> volume that is associated with a parallel improvement in neurological functional outcome and neurogenesis in the dentate gyrus of hippocamp </plain></SENT>
</text></document>